Citigroup Inc Bio N Tech Se Put Options Transaction History

Citigroup Inc

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 12, 2024	BUY	$78.36 - $124.66 $7.69 Million - $12.2 Million	98,100 Added 393.98%	123,000 $14.6 Million
Q2 2024 Aug 12, 2024	BUY	$80.36 - $102.87 $2 Million - $2.56 Million	24,900 New	24,900 $2 Million
Q4 2023 Feb 09, 2024	BUY	$90.91 - $112.75 $1.84 Million - $2.28 Million	20,200 New	20,200 $2.13 Million
Q2 2022 Aug 10, 2022	SELL	$123.25 - $186.24 $4.72 Million - $7.13 Million	-38,300 Reduced 65.69%	20,000 $2.98 Million
Q4 2021 Feb 10, 2022	SELL	$216.64 - $362.52 $10.1 Million - $16.9 Million	-46,600 Reduced 44.42%	58,300 $15 Million
Q3 2021 Nov 10, 2021	BUY	$205.93 - $447.23 $21.6 Million - $46.9 Million	104,900 New	104,900 $28.6 Million

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.